Horizon Discovery (Revvity)
Acquired by PerkinElmer/Revvity.
More about Horizon Discovery (Revvity)
Revvity, Inc. is a science-based solutions company focused on the life sciences and diagnostics sectors. Established in 2023 from a corporate split of PerkinElmer, Inc., it is headquartered in Waltham, Massachusetts, and employs over 11,000 people across 190 countries. The company generates annual revenue exceeding $3 billion and aims to expand human potential through science. Revvity offers a wide range of products and services, including reagents, consumables, assays, instruments, and software designed for biomedical research and diagnostics. Their key offerings encompass discovery tools, preclinical and development platforms, clinical and diagnostic solutions, and specialized areas such as in vivo imaging systems and reproductive health solutions. The company serves pharmaceutical and biotechnology firms, diagnostic labs, academic institutions, government agencies, and contract research organizations worldwide, supporting decision-making from research to clinical applications.
Live roles
Alert me when Horizon Discovery (Revvity) posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- University of Cambridge 26 live
Research-academic roles spanning bioinformatics, exascale computing and engineering.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.
- Illumina 6 live
Cambridge-based (Chesterford Research Park) arm of Illumina developing DNA sequencing instruments and technology.
- Bango 2 live
Cambridge mobile payments and content-subscription bundling platform; LSE-listed.
- Bicycle Therapeutics 2 live
Cambridge biotech; bicyclic peptide drug platform, oncology focus.